Delivery Order SPE2DB22D3501-SPE2DB25FTW46

Award Date 12/18/24
Potential Completion Date 12/19/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FTW46
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 18, 2024. The contract, valued at $11,163.16, is for the delivery of 4,566,761,020 Terbinafine HCL 250 mg tablets in 100-count bottles.

The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and has a history of providing pharmaceutical products and medical supplies to federal government agencies, particularly the DLA and the Department of Justice Federal Bureau of Investigation.

This contract award is likely part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC allows the government to efficiently procure a comprehensive range of pharmaceutical and medical products to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 3/19/25, 9:51 AM